Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

New approach improves SCA1 symptoms in animal models

Research has shown that a mutation in the ATAXIN-1 gene leads to accumulation of Ataxin-1 (ATXN1) protein in brain cells and is the root cause of a rare genetic neurodegenerative disease known as spinocerebellar ataxia type 1 (SCA1).

7 Aug 2020

Study: Individuals who feel dizzy when they stand up may have an increased risk of dementia

Some people who feel dizzy or lightheaded when they stand up may have an increased risk of developing dementia years later, according to a new study published in Neurology®, the medical journal of the American Academy of Neurology.

7 Aug 2020

Anxiety and depression coexisting could cause physical changes to the brain

A new study from the researchers at the Australian National University shows that there may be physical changes in the brain volume among persons who have coexisting and anxiety and depressive disorders.

6 Aug 2020

WVU RNI expands pioneering treatment for Alzheimer’s to open the blood-brain barrier

A hospital nurse for 33 years, Nanette Miller would call her husband Frank at the end of each shift to let him know she was coming home. On Dec. 7, 2018, the phone call came with a somber declaration: "I can't do this anymore."

6 Aug 2020

Body weight seriously impacts brain activity and blood flow

As a person's weight goes up, all regions of the brain go down in activity and blood flow, according to a new brain imaging study in the Journal of Alzheimer's Disease.

5 Aug 2020

GADL1 enzyme may be linked to athletic performances, shows study

Carnosine and its precursor beta-alanine increases muscle strength, and have recently become extremely popular as dietary supplements in competitive sports.

5 Aug 2020

Pharmacists look at deprescribing to reduce the risk of medicine-related harm

In an article published today in Australian Prescriber, pharmacist Michelle Liacos from Alfred Health in Melbourne, and her co-authors, look at stopping medicines when they are no longer needed to reduce the risk of medicine-related harm.

5 Aug 2020

Drug candidate successfully reversed memory loss in mouse model of Alzheimer's disease

A drug candidate developed by Salk researchers, and previously shown to slow aging in brain cells, successfully reversed memory loss in a mouse model of inherited Alzheimer's disease.

5 Aug 2020

New computational model can help determine drug viability

About 50% of people who take the drug infliximab for inflammatory bowel diseases, such as Crohn's disease, end up becoming resistant or unresponsive to it.

5 Aug 2020

Study shows how amyloid fibrils in Alzheimer's dissociate with infrared laser irradiation

The agglomeration of proteins into structures called amyloid plaques is a common feature of many neurodegenerative diseases, including Alzheimer's.

4 Aug 2020

Artificial intelligence can increase effectiveness of drug repurposing for psychiatric disorders

Artificial intelligence can increase the effectiveness of drug repositioning or repurposing research, according to a study published in Translational Psychiatry.

3 Aug 2020

UVA now supports engineering-to-medicine faculty fellowships

The University of Virginia's Center for Engineering in Medicine now supports faculty fellowships that embed engineering faculty members within the UVA School of Medicine.

31 Jul 2020

Using personalized precision medicine to treat cognitive decline

Latest research from Affirmativ Health succeeds in treating cognitive decline using personalized, precision medicine.

31 Jul 2020

Personalized, precision approach can reverse memory loss in Alzheimer’s patients

Cognitive decline is a major concern of the aging population. Already, Alzheimer's disease affects approximately 5.4 million Americans and 30 million people globally. Without effective prevention and treatment, the prospects for the future are bleak.

31 Jul 2020

Discovery could have important implications for brain infections, neurodegenerative diseases

More than 30 million Americans are infected with a brain parasite spread by cats and contaminated meat, but most will never show symptoms.

31 Jul 2020

Scientists develop a blood test that can spot Alzheimer's disease early

Alzheimer's disease is an irreversible neurodegenerative disease, and there is still no way to treat it. Many cases of the condition are diagnosed when the disease has already progressed, making it difficult to manage. Now, researchers have developed a new test that can spot Alzheimer's disease early on.

30 Jul 2020

Mice born with Fragile X syndrome have fewer cell antennas

Structures called primary cilia - which act like TV antennas for cells to detect signals - are present in fewer numbers in mice born with Fragile X syndrome, according to researchers from The University of Texas Health Science Center at San Antonio.

30 Jul 2020

Pimavanserin reduced psychotic symptoms in people with dementia in phase 3 study

A large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in people with dementia, a condition for which no treatments are currently licensed.

29 Jul 2020

New method can detect small amounts of protein fragment linked to Alzheimer's disease

Researchers at Washington University School of Medicine in St. Louis have developed a technique to detect minute amounts of a protein fragment linked to Alzheimer's disease in the blood.

29 Jul 2020

Simple blood test may be a great advance for people with and at risk for Alzheimer's

A simple blood test for Alzheimer's would be a great advance for individuals with - and at risk for - the disease, families, doctors and researchers.

28 Jul 2020

Alzheimer's Disease News and Research

Further Reading

New approach improves SCA1 symptoms in animal models

Study: Individuals who feel dizzy when they stand up may have an increased risk of dementia

Anxiety and depression coexisting could cause physical changes to the brain

WVU RNI expands pioneering treatment for Alzheimer’s to open the blood-brain barrier

Body weight seriously impacts brain activity and blood flow

GADL1 enzyme may be linked to athletic performances, shows study

Pharmacists look at deprescribing to reduce the risk of medicine-related harm

Drug candidate successfully reversed memory loss in mouse model of Alzheimer's disease

New computational model can help determine drug viability

Study shows how amyloid fibrils in Alzheimer's dissociate with infrared laser irradiation

Artificial intelligence can increase effectiveness of drug repurposing for psychiatric disorders

UVA now supports engineering-to-medicine faculty fellowships

Using personalized precision medicine to treat cognitive decline

Personalized, precision approach can reverse memory loss in Alzheimer’s patients

Discovery could have important implications for brain infections, neurodegenerative diseases

Scientists develop a blood test that can spot Alzheimer's disease early

Mice born with Fragile X syndrome have fewer cell antennas

Pimavanserin reduced psychotic symptoms in people with dementia in phase 3 study

New method can detect small amounts of protein fragment linked to Alzheimer's disease

Simple blood test may be a great advance for people with and at risk for Alzheimer's

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News